CLOs on the Move

Zogenix

www.zogenix.com

 
Zogenix is a global pharmaceutical company committed to developing and commercializing therapies with the potential to transform the lives of patients and their families living with rare diseases. The company has two late-stage development programs underway: FINTEPLA® (ZX008, fenfluramine oral solution) for the treatment of seizures associated with Dravet and Lennox-Gastaut syndromes, two rare and often-catastrophic childhood-onset epilepsies, and MT1621, a novel substrate enhancement therapy for the treatment of a rare genetic disorder called TK2 deficiency.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.zogenix.com
  • 5959 Horton Street
    Emeryville, CA USA 94608
  • Phone: 858.259.1165

Executives

Name Title Contact Details
Shawnte Mitchell
Executive Vice President, General Counsel and Corporate Secretary Profile
Shawnte Mitchell
Executive Vice President, General Counsel and Corporate Secretary Profile
Julien Capers
Assistant General Counsel Profile

Similar Companies

BTL Industries

Founded in 1993, BTL has grown to become one of the world’s major manufacturers of medical equipment. BTLs major segments include physical therapy, cardiology and medical aesthetics.

Girling Health Care

The Girling Difference Girling Health Care of NY is a leading provider of home health and home concierge care services. We provide personalized, professional care for patients in the comfort of their homes. Our services include home companions, skilled...

STI Technologies

STI Technologies Limited (STI) is a health-care technology company that provides Canadian patients with greater choice and broader access to the best medications and health care products.

Colorcon

Colorcon is a West Point, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.